HIGH-GRADE OSTEOSARCOMA

Clinical trials for HIGH-GRADE OSTEOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH-GRADE OSTEOSARCOMA trials appear

Sign up with your email to follow new studies for HIGH-GRADE OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo aims to improve survival in young bone cancer patients

Disease control Recruiting now

This study tests whether adding the drug cabozantinib to standard chemotherapy works better than chemo alone for people under 40 with newly diagnosed osteosarcoma, a type of bone cancer. Cabozantinib blocks signals that help tumors grow and form blood vessels. The trial will chec…

Matched conditions: HIGH-GRADE OSTEOSARCOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 11, 2026 20:40 UTC

HIGH-GRADE OSTEOSARCOMA

Get alerted when new HIGH-GRADE OSTEOSARCOMA trials appear

New drug combo aims to improve survival in young bone cancer patients